United States First Circuit
US ex rel. Ge v. Takeda Pharmaceutical Company, 13-1089
Dismissal of two qui tam actions alleging that defendant failed to disclose adequately the risks associated with four of its drugs and generally that this failure resulted in the submission of false claims by various third-party patients and physicians for government payment through, for example, Medicare or Medicaid reimbursement, is affirmed, where: 1) under Federal Rule of Civil Procedure 9(b), plaintiff failed to plead fraud with particularity; and 2) the district court did not abuse its discretion in denying plaintiff's requests to amend her complaints.
Appellate Information
- Decided 12/06/2013
- Published 12/06/2013
Judges
- LYNCH
Court
- United States First Circuit